2016 Innovation Grants - Professor Des Richardson
New therapeutic tools
Professor Des Richardson
Grant
Development of Novel Agents that Target P-Glycoprotein Resistant Pancreatic Cancer
Award
2015 Innovation Grant
Institution
University of Sydney
Drug resistance is a major factor underlying the limited response of pancreatic cancer to chemotherapy. The project team’s drug design strategy is to target resistant pancreatic cancer by taking advantage of detoxifying P-glycoprotein pump to transport our drugs DIRECTLY to their sensitive site of action in the cancer cell (namely, the LYSOSOME).
Professor Des Richardson